Advertisement
Advertisement
MRK
Merck & Co., Inc.
121.95
USDSponsored
+2.20
+1.84%
Feb 06, 16:00 UTC -5
Closed
After-Market
122.03
+0.08
+0.06%
MRK Earnings Reports
Positive Surprise Ratio
MRK beat 34 of 40 last estimates.
85%
Next Report
Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$16.50B
/-$1.31
Implied change from Q4 25 (Revenue/ EPS)
+0.63%
/-164.22%
Implied change from Q1 25 (Revenue/ EPS)
+6.28%
/-159.01%
Merck & Co., Inc. earnings per share and revenue
On Feb 03, 2026, MRK reported earnings of 2.04 USD per share (EPS) for Q4 25, beating the estimate of 2.02 USD, resulting in a 0.52% surprise. Revenue reached 16.40 billion, compared to an expected 16.35 billion, with a 0.31% difference. The market reacted with a +2.18% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of -1.31 USD, with revenue projected to reach 16.50 billion USD, implying an decrease of -164.22% EPS, and increase of 0.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eli Lilly & Co.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$6.73
Actual
$7.54
Surprise
+11.92%
ABBVIE INC.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.70
Actual
$2.71
Surprise
+0.17%
Novartis AG
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.02
Actual
$2.02
Surprise
+0.27%
Novo-Nordisk A/S
Report Date
Feb 04, 2026 For Q4 25
Estimate
$5.97
Actual
$6.32
Surprise
+5.77%
Pfizer Inc.
Report Date
Feb 03, 2026 For Q4 25
Estimate
$0.57
Actual
$0.66
Surprise
+14.29%
Sanofi - ADR
Report Date
Jan 29, 2026 For Q4 25
Estimate
$1.46
Actual
$1.53
Surprise
+4.22%
FAQ
What were Merck & Co., Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Merck & Co., Inc. reported EPS of $2.04, beating estimates by 0.52%, and revenue of $16.40B, 0.31% above expectations.
How did the market react to Merck & Co., Inc.'s Q4 2025 earnings?
The stock price moved up 2.18%, changed from $113.37 before the earnings release to $115.84 the day after.
When is Merck & Co., Inc. expected to report next?
The next earning report is scheduled for Apr 30, 2026.
What are the forecasts for Merck & Co., Inc.'s next earnings report?
Based on 12
analysts, Merck & Co., Inc. is expected to report EPS of -$1.31 and revenue of $16.50B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement